A thermodynamic based approach on the investigation of a diflunisal pharmaceutical co-crystal with improved intrinsic dissolution rate

被引:36
|
作者
Evora, Antonio O. L. [1 ]
Castro, Ricardo A. E.
Maria, Teresa M. R. [1 ]
Silva, M. Ramos [2 ]
ter Horst, J. H. [3 ]
Canotilho, Joao
Eusebio, M. Ermelinda S. [1 ]
机构
[1] Univ Coimbra, Dept Chem, P-3004535 Coimbra, Portugal
[2] Univ Coimbra, Dept Phys, P-3004535 Coimbra, Portugal
[3] Delft Univ Technol, Proc & Energy Dept, NL-2628 CB Delft, Netherlands
关键词
Diflunisal; Nicotinamide; Co-crystal; Binary phase diagram; Ternary phase diagram; Intrinsic dissolution rate; CARBOXYLIC-ACIDS; INFRARED-SPECTRA; HYDROGEN-BOND; TRANSTHYRETIN; COCRYSTALS; COMPLEXES; CRYSTALLIZATION; CALORIMETRY; ENTHALPY;
D O I
10.1016/j.ijpharm.2014.02.048
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A thermodynamic based approach is used to investigate diflunisal + nicotinamide binary and solution mixtures. A 2:1 co-crystal could be prepared by liquid assisted ball mill grinding and by solution crystallization from ethanol. The diflunisal + nicotinamide + ethanol ternary phase diagram points out conditions for co-crystal scaling-up. From the diflunisal + nicotinamide binary phase diagram, besides identification of the co-crystal stoichiometry, two additional useful binary compositions, eutectic mixtures, were characterized. From a solution enthalpy based approach, the enthalpic stabilization of the co-crystal relative to the pure solid components is quantified. Intrinsic dissolution rate, IDR, in test conditions consistent with USP requirements, including those referred in the diflunisal tablet monograph, were carried out, indicating that the co-crystal improves diflunisal IDR by about 20%. The systematic study of diflunisal + nicotinamide mixtures presented in this work is of particular interest due to the relevance of diflunisal, both as a non-steroidal anti-inflammatory drug and also due to the potentiality of orally administrated diflunisal in familial amyloid polyneuropathy. (C) 2014 Elsevier B. V. All rights reserved.
引用
收藏
页码:68 / 75
页数:8
相关论文
共 19 条
  • [1] Thermodynamic Approach for Co-crystal Screening
    Veith, Heiner
    Schleinitz, Miko
    Schauerte, Carsten
    Sadowski, Gabriele
    CRYSTAL GROWTH & DESIGN, 2019, 19 (06) : 3253 - 3264
  • [2] Structural investigation of a 2:1 co-crystal between diflunisal and isonicotinamide based on terahertz and Raman spectroscopy
    Wang, Yaguo
    Xue, Jiadan
    Wang, Qiqi
    Jin, Shunji
    Zhang, Ziming
    Hong, Zhi
    Du, Yong
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2019, 216 : 98 - 104
  • [3] Thermodynamic Investigation of Carbamazepine-Saccharin Co-Crystal Polymorphs
    Pagire, Sudhir K.
    Jadav, Niten
    Vangala, Venu R.
    Whiteside, Benjamin
    Paradkar, Anant
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (08) : 2009 - 2014
  • [4] Evaluation of Drug Dissolution Rate in Co-amorphous and Co-crystal Binary Drug Delivery Systems by Thermodynamic and Kinetic Methods
    Hu, Chunhui
    Zhang, Fabin
    Fan, Haining
    AAPS PHARMSCITECH, 2021, 22 (01)
  • [5] Evaluation of Drug Dissolution Rate in Co-amorphous and Co-crystal Binary Drug Delivery Systems by Thermodynamic and Kinetic Methods
    Chunhui Hu
    Fabin Zhang
    Haining Fan
    AAPS PharmSciTech, 22
  • [6] Aerosil as a novel co-crystal co-former for improving the dissolution rate of hydrochlorothiazide
    El-Gizawy, Sanaa A.
    Osman, Mohamed A.
    Arafa, Mona F.
    El Maghraby, Gamal M.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 478 (02) : 773 - 778
  • [7] Combination of co-crystal and nanocrystal techniques to improve the solubility and dissolution rate of poorly soluble drugs
    Huang, Zun
    Staufenbiel, Sven
    Bodmeier, Roland
    PHARMACEUTICAL RESEARCH, 2022, 39 (05) : 949 - 961
  • [8] Combination of co-crystal and nanocrystal techniques to improve the solubility and dissolution rate of poorly soluble drugs
    Zun Huang
    Sven Staufenbiel
    Roland Bodmeier
    Pharmaceutical Research, 2022, 39 : 949 - 961
  • [9] Solid phase drug-drug pharmaceutical co-crystal formed between pyrazinamide and diflunisal: Structural characterization based on terahertz/Raman spectroscopy combining with DFT calculation
    Wu, Xiushan
    Wang, Yaguo
    Xue, Jiadan
    Liu, Jianjun
    Qin, Jianyuan
    Hong, Zhi
    Du, Yong
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2020, 234
  • [10] Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets
    Arafa, Mona F.
    El-Gizawy, Sanaa A.
    Osman, Mohamed A.
    El Maghraby, Gamal M.
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2018, 23 (05) : 454 - 463